KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Alnylam Pharmaceuticals (ALNY) Cost of Revenue (2019 - 2025)

Alnylam Pharmaceuticals' Cost of Revenue history spans 7 years, with the latest figure at $267.7 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 160.81% year-over-year to $267.7 million; the TTM value through Dec 2025 reached $677.2 million, up 120.93%, while the annual FY2025 figure was $677.2 million, 120.93% up from the prior year.
  • Cost of Revenue reached $267.7 million in Q4 2025 per ALNY's latest filing, up from $197.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $267.7 million in Q4 2025 to a low of $23.0 million in Q1 2021.
  • Average Cost of Revenue over 5 years is $75.4 million, with a median of $60.9 million recorded in 2024.
  • Peak YoY movement for Cost of Revenue: dropped 10.71% in 2024, then soared 160.81% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $33.6 million in 2021, then soared by 37.27% to $46.2 million in 2022, then skyrocketed by 55.88% to $72.0 million in 2023, then surged by 42.62% to $102.6 million in 2024, then soared by 160.81% to $267.7 million in 2025.
  • Per Business Quant, the three most recent readings for ALNY's Cost of Revenue are $267.7 million (Q4 2025), $197.2 million (Q3 2025), and $142.0 million (Q2 2025).